Equities researchers at Huntington assumed coverage on shares of National Health Investors (NYSE:NHI – Get Free Report) in a research note issued on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $79.00 price target on the real estate investment trust’s stock. Huntington’s price objective would indicate a potential upside of 12.68% from the company’s current price.
Other research analysts also recently issued research reports about the stock. National Bank Financial set a $79.00 target price on shares of National Health Investors in a report on Wednesday. Deutsche Bank Aktiengesellschaft lowered their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday, June 25th. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. BMO Capital Markets lowered their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Finally, Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and an average price target of $82.25.
Get Our Latest Analysis on NHI
National Health Investors Stock Down 1.8%
National Health Investors (NYSE:NHI – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The company had revenue of $121.32 million for the quarter. During the same period in the prior year, the business earned $1.22 EPS. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts forecast that National Health Investors will post 4.76 EPS for the current year.
Insider Buying and Selling
In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of National Health Investors stock in a transaction on Monday, June 15th. The stock was bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 2.70% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in National Health Investors in the 2nd quarter valued at $665,997,000. California State Teachers Retirement System boosted its position in shares of National Health Investors by 7,748.8% during the 2nd quarter. California State Teachers Retirement System now owns 4,077,393 shares of the real estate investment trust’s stock valued at $310,942,000 after acquiring an additional 4,025,444 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in National Health Investors in the second quarter valued at about $122,509,000. Bank of America Corp DE bought a new stake in National Health Investors in the second quarter valued at about $77,738,000. Finally, Norges Bank acquired a new position in National Health Investors in the fourth quarter worth about $55,301,000. 62.51% of the stock is owned by institutional investors.
About National Health Investors
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Stories
- Five stocks we like better than National Health Investors
- Palantir’s New U.S. Army Contract Brings It Closer to Owning the Full Battlefield System
- Life Time Keeps Beating Expectations, But Insiders Are Selling Into Strength
- Sezzle’s BNPL Growth Is Working, But the Stock Comes With a Catch
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
